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Abstract
Impaired T cell reactivity is a feature of C3 deficient mice in several disease models. The mechanism behind the reduced T cell response is however poorly understood. We explored the hypothesis that antigen-presenting cells (APCs) from C3 -/-mice have impaired potency to stimulate antigen-specific T cells, in an alloantigen dependent model. Our results show that C3 -/-macrophages have reduced ability to elicit alloreactive T cell responses in vitro and in vivo, affecting both the primary and secondary responses. The C3 status of donor macrophages had a major impact on the CD4 T cell response. The impaired CD4 T cell response was associated with reduced expression of MHC class II on the surface of C3 -/-macrophages, without loss of class II gene expression.
Furthermore, inhibition of C3 gene expression in C3 +/+ macrophages reduced their ability to stimulate alloreactive T cells, suggesting that endogenous production of C3 could in part contribute to the potency of APCs. Our data provide compelling evidence that C3 deficiency modulates the potency of APCs to stimulate the T cell response, suggesting a critical role for complement in the maintenance of APC function. This could offer a partial explanation as to why the T cell response is impaired in C3 -/-mice.
Introduction
Recent evidence has emphasized the importance of the innate immune system in the establishment of the adaptive immune response 1 . The complement system is an important component of innate immunity. In addition to its pivotal role in the regulation of inflammation and host defence, the complement system also participates in regulating the antigen specific immune response 2, 3 . The activation of C3 is the converging point of the three pathways, from where effector functions of complement are generated. Therefore, C3 is vital for participation of the complement system in both the innate and adaptive immune responses.
C3, the most abundant complement protein in serum (1.3 mg/ml in man), is an acute-phase protein and rapidly responds to many noxious stimuli including microbial infection and tissue injury. The liver is the primary source for the synthesis of C3 4 ; however, many other specialized cells have the capacity to synthesise C3 including myeloid derived cells and parenchymal cells [5] [6] [7] [8] [9] . These cells synthesize C3 spontaneously or in response to cytokine stimulation. Extrahepatic synthesis of C3 is thought to serve important physiological and pathological functions, in terms of regulation of the inflammatory response, host defence and allograft rejection [10] [11] [12] [13] .
Human and animal studies have demonstrated the importance of C3 in the adaptive immune response 14, 15 . C3 -/-mice exhibit an impaired B cell response to both T cell-independent anddependent antigens . The mechanism of complement regulation of the B cell response appears to involve the interaction of complement activation products (C3b, C3d) and complement receptors 1 and 2 (CR1/CD35, CR2/CD21) on cell surfaces, thus increasing the retention of antigen in lymphoid tissue and enhancing the B cell response 16, 17 . In addition to the regulation of B cell responses, participation of complement in T cell immunity has more recently been described. Impaired T cell responses in C3 -/-mice were reported in several disease models including viral infection, autoimmune disease and transplantation [18] [19] [20] [21] . However the means by which C3 deficiency leads to impaired antigen-specific T cell reactivity in such conditions remains unclear.
Although T cell priming is impaired in C3 -/-mice in the influenza virus model, T cell priming is normal in mice deficient of CD35 and CD21 18 . This suggests that the complement receptors CD35
and CD21 are not involved in the development of T cell reactivity; therefore, the mechanism for C3 regulating T cell responses may differ from that regulating the B cell response. Previous studies have found that antigen coupled covalently to C3b is protected from excessive proteolytic degradation in the endosomal/lysosomal compartment of the MHC class II pathway in B cells. This enhances peptide loading onto MHC class II molecules and increases stable MHC class II molecules in this compartment [22] [23] [24] . These studies suggest that activated C3 fragment functions as a "chaperone" in the MHC class II pathway of APCs, which is essential for maintaining the normal In this study, we explored the hypothesis that C3 deficiency reduces the potency of APCs to stimulate T cell responses. We examined an alloantigen dependent model of T cell stimulation using macrophages from C57BL/6 mice as stimulators and splenic T cells from BALB/c mice as responders. We assessed the alloreactive T cell response in vitro and in vivo following stimulation with C3
+/+ and C3 -/-macrophages. We assessed the gene and cell surface protein expression of MHC class II and co-stimulatory molecules. We also investigated the role of endogenous production of C3
by macrophages in alloreactive T cell response and the way that this production might increase the capacity of macrophages to stimulate alloreactive T cells.
Materials and Methods
Mice. Homozygous C3 -/-, C4 -/-and factor B (FB) -/-mice were derived by homologous recombination in embryonic stem cells [25] [26] [27] and backcrossed on to the C57BL/6 parental strain for 11 generations.
WT (C57BL/6 H-2b ) mice, BALB/c H-2d mice were purchased from Harlan UK. Male mice (6-7 week old) were used in all experiments. All animal procedures were carried out within the Animals (Scientific Procedures) Act, 1986 UK.
Preparation of macrophages.
Resident and thioglycollate-elicited peritoneal macrophages and bone marrow (BM) macrophages were prepared using previously described methods 28 (see the details in Supplementary Methods). Macrophages were further purified with CD11b MicroBeads (Miltenyi Biotec UK) according to manufacturer's instruction, unless otherwise specified.
Following the purification, 85-90% of cells were found to stain positive with anti-mouse F4/80 as determined by flow cytometry (Supplementary Figure 1) . In each experiment, macrophages were prepared from 3-5 mice and pooled together for analysis, unless otherwise stated. Thioglycollateelicited macrophages were used in the majority of our experiments, unless otherwise specified.
Preparation of T cells. Naive alloreactive T cells were derived from spleens of normal BALB/c mice. Primed alloreactive T cells were derived from BALB/c mice that had received a C57BL/6 skin graft 14 days in advance. CD3 + , CD4 + and CD8 + T cells were prepared from splenocytes using SpinSep TM Enrichment Cocktail Kit (StemCell Technology Inc., UK). Following the isolation, the purity of the T cell preparation was routinely >90%, as determined by flow cytometry. T cells were prepared from 3-6 mice depending on the number of purified T cells needed in each experiment. using siRNA transfection kit (Qiagen, UK). After 48h transfection, the reduction of C3 synthesis by macrophages was measured by quantitative real-time RT-PCR and ELISA. After 48h transfection, macrophages were also co-cultured with primed alloreactive T cells for up to 2 days. Supernatants were collected and used for measuring the production of cytokine by ELISA. Statistical analysis. ELISA or T cell proliferation assays were performed in 3-6 replicate wells of the co-cultures. Results were expressed as a mean ± SEM and subjected to statistical analysis.
Student's t test or Two-way ANOVA or variance component regression analysis was used where appropriate to determine significant differences between samples. Graft survival was analyzed by Log-rank test. All experiments were repeated at least three times. In our initial study, we also assessed the proliferative T cell response after stimulation by allogeneic macrophages. T cell proliferation following stimulation by C3 -/-macrophages was reduced compared to C3 +/+ macrophages (Fig. 1B ).
Results

C3
C3 gene silenced macrophages have lowered ability to stimulate alloreactive T cells
Since macrophages derived from C3 deficient mice exhibited a low level of T cell stimulation, we wished to verify if this effect was attributable to C3 production by the macrophages. For this purpose, we inhibited C3 gene expression in C3 +/+ macrophages using small interfering RNA and measured the ability of these macrophages to stimulate alloreactive T cells compared with controltreated macrophages. As shown in Figure 2 , treatment with interfering RNA significantly reduced the amount of C3 mRNA and C3 secretion, and co-ordinately lowered the level of T cell activation stimulated by these macrophages. However, treatment with irrelevant interfering RNA did not show significant reduction in the amount of C3 produced or in the level of T cell activation. This is consistent with an effect of endogenous production of C3 on the potency of macrophages to stimulate alloreactive T cells.
Dependence of the CD4 T cell response on the C3 status of donor macrophages
To determine which of the two main subpopulations of T cells, CD4 or CD8, was more reactive to the C3 status of the stimulator cells, we performed a 5-day co-culture experiment where the purified CD3 + , CD4 + and CD8 + T cells were stimulated respectively by C3 +/+ or C3 -/-macrophages. We found that the production of IL-2 ( Fig. 3A) and IFN-γ (Fig. 3B) The macrophages in the above experiments were prepared from the inflamed peritoneum of thioglycollate treated mice. We also prepared macrophages from the normal peritoneal cavity and BM of WT and C3 -/-mice without further purification with CD11b beads. Then, we stimulated them with LPS (100ng/ml) for 24 hours and subsequently co-cultured these macrophages with primed alloreactive CD4 + T cells and assessed the T cell response. We found that the production of IFN-γ and IL-2 was consistently lower in T cells stimulated by C3 -/-macrophages compared with the T cells stimulated by C3 +/+ macrophages, for macrophages from both of these sources (Fig. 3C ). C3-dependent T cell stimulation was thus a feature of macrophages regardless of source or inflammatory status.
Reduced capacity of C3 -/-macrophages for immune stimulation in vivo
In the next set of experiments, we determined whether C3 -/-macrophages have a reduced ability to elicit an alloreactive T cell response in vivo. We examined two protocols. The first tested whether T cell priming was affected by the C3 status of donor macrophages. At day 0, BALB/c mice were given either C3 +/+ or C3 -/-C57BL/6 donor macrophages. As a read out of the T cell response, at day 14 after the injection of macrophages the mice received a skin graft from a C567BL/6 donor. On day 21, some mice were killed and their splenocytes were used for analysis of the alloreactive T cell response ex vivo using MLR. T cell activation was assessed by measuring the secretion of IL-2 and IFN-γ using ELISA. Other mice were kept for monitoring skin graft rejection. The T cell response in mice that had received C3 -/-macrophages was impaired, with significant lowering of IL-2 ( Fig.   4A ) and IFN-γ (Fig. 4Β ) production and prolonged graft survival (Fig. 4C ), compared to mice that had received C3 +/+ macrophages. Thus immunization with C3 -/-macrophages resulted in defective T cell priming in vivo.
We then tested whether the reactivation of previously primed T cells was affected by the C3 status of donor macrophages. At day 0, BALB/c mice received a C57BL/6 donor skin graft, and after 14 days the skin-grafted mice were given either C3 +/+ or C3 -/-macrophages. On day 21, the mice were killed and their splenocytes were used for analysis of the alloreactive T cell response ex vivo using MLR. We found that primed alloreactive T cells re-stimulated by C3 -/-macrophages in vivo produced less IFN-γ, compared to those re-stimulated by C3 +/+ macrophages in vivo (Fig. 4D) .
However, the production of IL-2 was no significantly different between re-stimulation with C3
-/-and C3 -/-macrophages (data not shown). Although the reason for this discrepancy between the IFN-γ and IL-2 responses is unclear, IFN-γ is the hallmark of Th1 lymphocytes, which are thought to be the predominant T cell population involved in the alloimmune response. On the basis of these results, both T cell priming and reactivation were impaired when stimulated by C3 -/-macrophages.
For
Reduced cell surface expression of MHC class II in C3 -/-macrophages
Full activation of T cells requires stimulating signals from both antigen (allo-MHC) and costimulatory molecules present on APCs. In order to assess the expression of MHC and costimulatory molecules, we first examined thioglycollate-elicited peritoneal macrophages. Using flow cytometry we found that the surface expression of MHC class II was reduced in C3 -/-cells compared with C3 +/+ cells ( Fig. 5A and 5B). However, cell surface staining for co-stimulatory molecules showed no reduction of expression of B7.2, ICAM-1 or CD40 on the C3 -/-cells (data not shown). To confirm our observations in a second macrophage population, we examined BM- 
surface-bound C3 fragment by flow cytometry. There were no detectable differences between C3 +/+ and C3 -/-macrophages (Fig. 6A) . Therefore the differences in T cell stimulation by C3 +/+ and C3 -/-macrophages in vitro could not be explained by macrophage-adherent C3.
Another possibility is that soluble fragments released after the cleavage of secreted C3 could interact with C3a and C5a receptors on APCs or T cells 33, 34 . We measured the amount of C3 secreted during co-culture in our experiments with irradiated C3 +/+ macrophages, and found only small quantities of C3 were produced (4-14ng/ml). To determine if this small amount of secreted C3 could explain the functional difference between C3 +/+ and C3 -/-macrophages, we performed a reconstitution study. We co-cultured C3 -/-macrophages with primed T cells in the presence of either 0.005% or 0.05% fresh WT mouse serum (which contains at least 10x the amount of C3 as secreted by our irradiated macrophages) or C3 -/-serum at the same concentration, and measured the T cell response. As shown in Figure 6B , the production of IFN-γ was not significantly increased by the addition of C3 in the In the all of aforementioned experiments the difference between C3 -/-and C3 +/+ macrophages in their ability to stimulate alloreactive T cells is not explained either by C3 fragment deposited on the macrophage surface or by the small amount of C3 released by irradiated cells in vitro. It is important to note that our data do not exclude the possibility of such effects occurring in vivo, thus promoting the interaction of macrophages and T cells.
Factor B -/-macrophages have impaired ability to elicit a T cell response
Since C3 -/-macrophages originate from an environment in which complement activation is lacking, we postulated that other factors required for complement activation might produce a similar effect on macrophage function. We therefore assessed the influence of Factor B (alternative pathway) and C4 (classical and lectin pathways) on macrophage induced T cell stimulation. Macrophages derived from C3 -/-, Factor B -/-and C4 -/-mice were evaluated in T cell cytokine and proliferation assays. The results are presented in Figures 7A and 7B , respectively. These confirm that the macrophage-effect on the stimulation of primed T cells is dependent on C3. Additionally, the data show that macrophages from Factor B -/-mice elicit weaker T cell responses compared to wild type macrophages, although the effect of Factor B is not as pronounced as for C3. In contrast, the T cell response with C4 -/-macrophages was unimpaired. This suggests that the effect of C3 in augmenting the T cell response may partly depend on activation through the alternative pathway, but not through the classical and lectin pathways.
Discussion
While the effect of complement on B cell regulation has been comprehensively studied, the way in which C3 stimulates the T cell response is poorly understood. Our results show that macrophages from C3 deficient mice have reduced ability to stimulate alloreactive T cells. These findings, shown both for T cell priming and T cell reactivation, in vitro and in vivo, suggest a critical role for complement in the maintenance of APC function.
The C3 knockout mouse used in our study was an 11 th generation backcross that exhibited indefinite skin graft survival with the wild type strain (C57BL/6). Thus it is unlikely that the C3 deficient and wild type macrophages had any significant differences at histocompatibility loci. Moreover we were unable to demonstrate defects in macrophage gene expression of several vital pathways involved in immune stimulation. Therefore the differences in T cell stimulation obtained with wild type and C3 deficient macrophages were not obviously explained by defects of other genes involved in antigen presentation. Although a mutant strain of mouse with spontaneous deficiency of C3 was not available, an inbred guinea pig strain with partial functional deficiency of C3 exists, and peritoneal macrophages from these guinea pigs were shown to elicit reduced T cell responses, against conventional antigens 32 . These observations offer strong support that the differences between deficient and wild type macrophages detected in our study are due to lack of C3.
The mechanism by which C3 enhances the T cell stimulatory capacity of macrophages has a number of possible explanations. The simplest of these is that macrophages derived from C3 deficient mice have an immature phenotype and are thus less competent to function as APC. The reduced cell surface MHC class II expression and associated defect of CD4 T cell stimulation found in our study could be an example of this. In vivo, complement activation can occur spontaneously under physiological conditions and increase rapidly in response to inflammatory stimuli 36, 37 .
Complement effector products may directly activate macrophages through engagement of C3a or C5a receptors on the macrophage surface or through membrane insertion with a sublethal dose of C5b-9 38, 39 . In addition, complement mediated local inflammation could indirectly activate macrophages through cytokine, autocrine and paracrine regulation 38 . Thus, deficiency of C3 or other activating factors required for the cleavage of C3, such as Factor B, would result in a less mature macrophage phenotype with reduced capacity for stimulating alloreactive T cells. It is also apparent from our results that Factor B had a weaker effect than C3 on the capacity of APCs for T Another possibility to explain the effect of complement is that membrane-bound fragments of C3 behave as adhesion molecules increasing the contact between macrophages and T cells, which are known to express receptors for such fragments 40, 41 . A similar model has been proposed in the study of conventional antigens 31, 32 . Thus, C3 receptor-ligand interaction may provide a bridge between these two types of cells, facilitating immune adherence and T cell activation. Our study differed from those with conventional antigen, in that alloantigen is synthesized by the donor APC, though may also be taken up by recipient APCs and presented to the immune system. Moreover, we were unable to show that the addition of complement could restore allo-stimulation by C3 deficient mouse macrophages or show an effect of C3 blockade in vitro. However, our findings do not preclude a role of C3 for opsonisation of APCs in vivo.
A third potential mechanism suggested by our data is that local production of C3 by donor APCs Finally, it has been proposed that C3 taken up with antigen via a complement-receptor dependent mechanism can modulate the presentation of antigen to T cells 43 . Using B cells as APCs, research has shown that C3-coupled antigen is protected from excessive proteolytic degradation in the endosomal/lysosomal compartment of the MHC class II pathway, suggesting that activated C3 fragment acts as a chaperone in this antigen presenting pathway [22] [23] [24] . It is therefore possible that C3, either synthesised or taken up by macrophages, could act as an adjuvant for alloantigen. Thus it could be speculated that the lowered expression of MHC class II on the surface of C3 deficient APC, presumably as a result of a post transcriptional mechanism, arises from defective antigen processing.
In conclusion our data show that macrophages derived from C3 deficient mice have impaired ability
to generate alloreactive T cell responses in vitro and in vivo. Although it is possible that APCs arising in a complement-deprived environment have defective maturation, the results of C3 gene silencing point to an additional mechanism that is dependent on the local synthesis of C3. This is the subject of ongoing studies. Thus, defective APC function offers an explanation, at least in part, for C3 deficient mice having impaired T cell responses. Additionally, our data that APC function could depend on the local synthesis of C3 may inform new approaches for vaccine development, cancer therapy and prevention of organ graft rejection. Thioglycollate-elicited macrophages were prepared from C3 +/+ and C3 -/-mice. Alloreactive CD3 + T cells were prepared from either naïve BALB/c mice or BALB/c mice that had been primed by grafting with C57BL/6 donor skin. Syngeneic CD3 + T cells were prepared from C57BL/6 mice. Figure 1A , 2 x 10 5 macrophages and 2 x 10 5 T cells were co-cultured for 3 days; supernatants were collected for measuring the production of IL-2 and IFN-γ by ELISA. Figure 1B , 2 x 10 5 macrophages and 1 or 2 x 10 5 T cells were co-cultured for 3 days, after which T cell proliferation and cytokine assays were performed. T cell proliferation was assessed using Non-Radioactive Cell Proliferation Assay Kit. The absorbance at 490nm reflecting the amount of formazan in cell culture medium was measured. All data were generated from 3 independent experiments with three mice/group in each experiment, and analyzed by Student's t test. P values are for comparisons between C3 +/+ and C3 -/-macrophages. *, P <0.05; **, P <0.005; ***, P <0.0001; ns, no significant difference. Thioglycollate-elicited C3 +/+ macrophages were transfected with 100 nM of either C3 siRNA or control siRNA using a siRNA transfection kit (Qiagen). After 48h transfection, C3 expression was measured by quantitative real-time RT-PCR ( Fig. 2A) and ELISA (Fig. 2B) . After 48h transfection, 1x10 5 macrophages were co-cultured with 1x10 5 primed alloreactive CD3 + T cells for 2 days.
Supernatants were collected and used for measuring the production of IL-2 by ELISA (Fig. 2C ). All data were generated from 3 independent experiments, with macrophages pooled from 5 mice in each experiment, and analyzed by Student's t test. P values are for comparisons between untreated C3 +/+ macrophages and other groups of macrophages, ***, P <0.0001; ns, no significant difference. In Figure 3A and 3B, thioglycollate-elicited macrophages were prepared from C3 +/+ and C3 -/-mice. Supernatants were collected for measuring the production of IL-2 ( Fig 3A) and IFN-γ (Fig. 3B) by ELISA. In Figure 3C , normal peritoneum or bone marrow (BM) macrophages were prepared from C3 +/+ and C3 -/-mice. The pooled macrophages without further purification with CD11b beads were stimulated with LPS (100ng/ml) for 24 hours, and then co-cultured with primed alloreactive CD4 + T cells for 3 days. Supernatants were collected for measuring the production of IL-2 and IFN-γ by ELISA. All data in Figure 3A and 3B were generated from 3 independent experiments, with 5
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From mice/group in each experiment. Data were analyzed by variance component regression analysis. In Figure 3C , the data were generated from 3 experiments, with 3 mice/group in each experiment, and analyzed by Two-way ANOVA. P values are for comparisons between C3 +/+ and C3 -/-macrophages. In Figure 5A and 5B, thioglycollate-elicited macrophages were prepared from C3 +/+ (n=6) and C3
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